Biochemical characterization of autologous fibrin sealants produced by CryoSeal® and Vivostat® in comparison to the homologous fibrin sealant product Tissucol/Tisseel®
- 1 November 2005
- journal article
- research article
- Published by Elsevier BV in Biomaterials
- Vol. 26 (31), 6233-6241
- https://doi.org/10.1016/j.biomaterials.2005.04.014
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Fibrin sealant produced by the CryoSeal® FS System: product chemistry, material properties and possible preparation in the autologous preoperative settingVox Sanguinis, 2004
- Fibrin Sealant Reduces Perioperative Blood Loss in Total Hip ReplacementJournal of Long-Term Effects of Medical Implants, 2003
- Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgeryThe Annals of Thoracic Surgery, 2002
- Physical Characteristics of Vivostat® Patient-Derived SealantEuropean Surgical Research, 2001
- Fibrin sealants in surgical practice: An overviewThe American Journal of Surgery, 2001
- Predicting the long‐term risk of HIV exposure by cryoprecipitateHaemophilia, 2000
- Covalent Cross-linking of Fibronectin to Fibrin Is Required for Maximal Cell Adhesion to a Fibronectin-Fibrin MatrixJournal of Biological Chemistry, 1997
- Fibrin Sealing: Physiologic and Biochemical BackgroundFacial Plastic Surgery, 1985
- Thrombin-like snake venom proteinasesToxicon, 1982
- Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag SystemNew England Journal of Medicine, 1965